Authors:
OFFNER F
CORDONNIER C
LJUNGMAN P
PRENTICE HG
ENGELHARD D
DEBACQUER D
MEUNIER F
DEPAUW B
Citation: F. Offner et al., IMPACT OF PREVIOUS ASPERGILLOSIS ON THE OUTCOME OF BONE-MARROW TRANSPLANTATION, Clinical infectious diseases, 26(5), 1998, pp. 1098-1103
Authors:
LARSEN J
GARDULF A
NORDSTROM G
BJORKSTRAND B
LJUNGMAN P
Citation: J. Larsen et al., HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS UNDERGOING BLOOD AND OR MARROW TRANSPLANTATION/, Psycho-oncology, 7(3), 1998, pp. 2135-2135
Citation: K. Larsson et al., FASTER ENGRAFTMENT BUT NO REDUCTION IN INFECTIOUS COMPLICATIONS AFTERPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION COMPARED TO AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Supportive care in cancer, 6(4), 1998, pp. 378-383
Authors:
CARLENS S
RINGDEN O
ASCHAN J
HAGGLUND H
LJUNGMAN P
MATTSSON J
REMBERGER M
Citation: S. Carlens et al., RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION, Clinical transplantation, 12(2), 1998, pp. 84-92
Authors:
CARLENS S
RINGDEN O
REMBERGER M
LONNQVIST B
HAGGLUND H
KLAESSON S
MATTSSON J
SVAHN BM
WINIARSKI J
LJUNGMAN P
ASCHAN J
Citation: S. Carlens et al., RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS, Bone marrow transplantation, 22(8), 1998, pp. 755-761
Authors:
SPARRELID E
HAGGLUND H
REMBERGER M
RINGDEN O
LONNQVIST B
LJUNGMAN P
ANDERSSON J
Citation: E. Sparrelid et al., BACTEREMIA DURING THE APLASTIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH EARLY DEATH FROM INVASIVE FUNGAL INFECTION, Bone marrow transplantation, 22(8), 1998, pp. 795-800
Authors:
LJUNGMAN P
BJORKSTRAND B
FORNANDER T
HOGLUND M
JULIUSSON G
LINDMAN H
MALMSTROM A
ROTSTEIN S
SODERBERG M
WILKING N
VILLMAN K
BERGH J
Citation: P. Ljungman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE-IV BREAST-CANCER, Bone marrow transplantation, 22(5), 1998, pp. 445-448
Authors:
LJUNGMAN P
HALASZ R
HAGGLUND H
SONNERBORG A
RINGDEN O
Citation: P. Ljungman et al., DETECTION OF HEPATITIS-G VIRUS GB-VIRUS-C AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(5), 1998, pp. 499-501
Authors:
HAMMARSTROM V
PAUKSEN K
BJORKSTRAND B
SIMONSSON B
OBERG G
LJUNGMAN P
Citation: V. Hammarstrom et al., TETANUS IMMUNITY IN AUTOLOGOUS BONE-MARROW AND BLOOD STEM-CELL TRANSPLANT RECIPIENTS, Bone marrow transplantation, 22(1), 1998, pp. 67-71
Authors:
REMBERGER M
RINGDEN O
LJUNGMAN P
HAGGLUND H
WINIARSKI J
LONNQVIST B
ASCHAN J
Citation: M. Remberger et al., BOOSTER MARROW OR BLOOD-CELLS FOR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(1), 1998, pp. 73-78
Authors:
LJUNGMAN P
CORDONNIER C
EINSELE H
BENDERGOTZE C
BOSI A
DEKKER A
DELACAMARA R
GMUR J
NEWLAND AC
PRENTICE HG
ROBINSON AJ
ROVIRA M
ROSLER W
VEIL D
Citation: P. Ljungman et al., USE OF INTRAVENOUS IMMUNE GLOBULIN IN ADDITION TO ANTIVIRAL THERAPY IN THE TREATMENT OF CMV GASTROINTESTINAL-DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANT PATIENTS - A REPORT FROM THE UROPEAN-GROUP-FOR-BLOOD-AND-MARROW-TRANSPLANTATION (EBMT), Bone marrow transplantation, 21(5), 1998, pp. 473-476
Authors:
RUNDE V
DEWITTE T
ARNOLD R
GRATWOHL A
HERMANS J
VANBIEZEN A
NIEDERWIESER D
LABOPIN M
WALTERNOEL MP
BACIGALUPO A
JACOBSEN N
LJUNGMAN P
CARRERAS E
KOLB HJ
AUL C
APPERLEY J
Citation: V. Runde et al., BONE-MARROW TRANSPLANTATION FROM HLA IDENTICAL SIBLINGS AS FIRST-LINETREATMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - EARLY TRANSPLANTATION IS ASSOCIATED WITH IMPROVED OUTCOME, Bone marrow transplantation, 21(3), 1998, pp. 255-261
Authors:
GUARDIOLA P
SOCIE G
PASQUINI R
DOKAL I
ORTEGA JJ
VANWEELSIPMAN M
MARSH J
LOCATELLI F
SOUILLET G
CAHN JY
LJUNGMAN P
MINIERO R
SHAW J
VERMYLEN C
ARCHIMBAUD E
BEKASSY AN
KRIVAN G
DIBARTOLOMEO P
BACIGALUPO A
GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FOR FANCONI-ANEMIA, Bone marrow transplantation, 21, 1998, pp. 24-27
Authors:
PASSWEG JR
ROWLINGS PA
ATKINSON KA
BARRETT AJ
GALE RP
GRATWOHL A
JACOBSEN N
KLEIN JP
LJUNGMAN P
RUSSELL JA
SCHAEFER UW
SOBOCINSKI KA
VOSSEN JM
ZHANG MJ
HOROWITZ MM
Citation: Jr. Passweg et al., INFLUENCE OF PROTECTIVE ISOLATION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA, Bone marrow transplantation, 21(12), 1998, pp. 1231-1238
Authors:
RINGDEN O
REMBERGER M
MATTSSON J
ASCHAN J
CARLENS S
HAGGLUND H
LONNQVIST B
SPARRELID E
LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Bone marrow transplantation, 21(1), 1998, pp. 43-49
Authors:
LARSSON K
WINIARSKI J
LONNQVIST B
RINGDEN O
LJUNGMAN P
Citation: K. Larsson et al., RESULTS OF BONE-MARROW TRANSPLANTATION IN PH-A, HLA-B AND HLA-DR IDENTICAL DONORS( ALL USING RELATED OR UNRELATED HLA), Bone marrow transplantation, 21, 1998, pp. 6-6
Authors:
RINGDEN O
REMBERGER M
CARLENS S
HAGGLUND H
MATTSSON J
ASCHAN J
LONNQVIST B
KLAESSON S
WINIARSKI J
DALIANIS T
OLERUP O
SPARRELID E
LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES, Bone marrow transplantation, 21, 1998, pp. 114-114
Authors:
HOWS J
BRADLEY B
SCHREZENMEIER H
BACIGALUPO A
MARSH J
TICHELLI A
MARIN P
LJUNGMAN P
Citation: J. Hows et al., SURVEY OF TRANSFUSION THERAPY IN PATIENTS WITH APLASTIC-ANEMIA (AA) IN EUROPE 1997, Bone marrow transplantation, 21, 1998, pp. 169-169
Authors:
LJUNGMAN P
BJORKSTRAND B
FORNANDER T
HOGLUND M
JULIUSSON G
MALMSTROM A
LINDMAN H
ROTSTEIN S
SODERBERG M
WILKING N
VILLMAN K
BERGH J
Citation: P. Ljungman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH RESPONDING STAGE IV BREAST-CANCER, Bone marrow transplantation, 21, 1998, pp. 219-219
Authors:
GUARDIOLA P
ANDERSON JE
BANDINI B
RUNDE V
BACIGALUPO A
CORNELISSEN JJ
RUUTU T
LJUNGMAN P
VANBIEZEN A
APPERLEY J
DEWITTE T
GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA - AN EBMT HUTCHINSON,F. CRC/SFGM COLLABORATIVE STUDY/, Bone marrow transplantation, 21, 1998, pp. 290-290
Authors:
NORDESJO G
LJUNGMAN P
BJORKSTRAND B
LINDBERG G
HELLSTROMLINDBERG E
Citation: G. Nordesjo et al., TREATMENT OF LONG-TERM ANOREXIA AND NAUSEA AFTER STEM-CELL TRANSPLANTATION WITH LOW-DOSE OCTREOTIDE, Bone marrow transplantation, 21, 1998, pp. 312-312
Authors:
HENTSCHKE P
HAGGLUND H
MATTSSON J
CARLENS S
LONNQVIST B
LJUNGMAN P
ASCHAN J
RINGDEN O
Citation: P. Hentschke et al., BILATERAL SUBDURAL HEMATOMAS FOLLOWING INTRATHECAL INJECTION IN 3 BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 21, 1998, pp. 326-326
Authors:
ASCHAN J
EMTESTAM L
LJUNGMAN P
LONNQVIST B
RINGDEN O
Citation: J. Aschan et al., PUVA TREATMENT FOR GRAFT-VERSUS-HOST DISEASE - A RETROSPECTIVE ANALYSIS, Bone marrow transplantation, 21, 1998, pp. 395-395